HIV/AIDS
Findings from France, the United States and BARBADOS advance knowledge in HIV/AIDS research
Published in AIDS Weekly, May 15th, 2006
Study 1: Long-term stavudine withdrawal may be associated with significant lipoatrophy improvement in the lower extremities.
In a recent report, researchers in France conducted an observational, retrospective study consisting of a cross-sectional (part 1) and a longitudinal (part 2) study to "determine whether discontinuation of stavudine or protease inhibitor therapy improves human immunodeficiency virus (HIV)-related fat distribution in men."
N. Tavassoli and colleagues at Toulouse Hospital wrote, "Medical records from Purpan University...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-05-15)
More Articles from AIDS Weekly
- HIV-1/HTLV-II Coinfection
HIV-1/HTLV-II coinfection associated with greater immunodeficiency - HIV/AIDS HAART
Permanent HIV suppression may be achieved with immunomodulants in association with HAART - HIV/AIDS Pathogenesis
HIV-1 pathogenesis predictions differ between three mathematical models - HIV/AIDS Pathogenesis
HIV-1 superinfected cells show increased mortality - HIV/AIDS Prognostic Indicator
Higher HIV viral load associated with mannose-binding lectin gene polymorphism - Antimicrobials
Alligator leukocyte extracts have broad spectrum antimicrobial activity - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
